Clinical Trial Update: Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Malignancies [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a conditioning regimen of fludarabine phosphate, busulfan, and anti-thymocyte globulin followed by donor peripheral blood stem cell tra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• BUSULFAN (Busulfan)
• Fludarabine phosphate (Fludarabine phosphate)
• METHOTREXATE (METHOTREXATE)
• Tacrolimus (Tacrolimus)
• anti-thymocyte globulin (antithymocyte globulin)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission | Phase 2 | Status: COMPLETED